These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20724959

  • 1. Cytomegalovirus mismatch as major risk factor for delayed graft function after pancreas transplantation.
    Maglione M, Biebl MO, Bonatti H, Göbel G, Ratschiller T, Schneeberger S, Brandacher G, Hengster P, Margreiter C, Berger N, Margreiter R, Pratschke J, Mark W.
    Transplantation; 2010 Sep 27; 90(6):666-71. PubMed ID: 20724959
    [Abstract] [Full Text] [Related]

  • 2. Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients.
    Narayanan R, Cardella CJ, Cattran DC, Cole EH, Tinckam KJ, Schiff J, Kim SJ.
    Am J Kidney Dis; 2010 Nov 27; 56(5):961-70. PubMed ID: 20870331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Delayed graft function after renal transplantation: an unresolved problem.
    Gavela Martínez E, Pallardó Mateu LM, Sancho Calabuig A, Beltrán Catalán S, Kanter Berga J, Ávila Bernabeu AI, Crespo Albiach J.
    Transplant Proc; 2011 Nov 27; 43(6):2171-3. PubMed ID: 21839224
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of the influence of donor and recipient cytomegalovirus sero-pairing on outcomes in simultaneous kidney-pancreas transplantation: the South-Eastern Organ Procurement Foundation Experience.
    Stratta RJ, Thacker LR, Sundberg AK, South-Eastern Organ Procurement Foundation.
    Transplant Proc; 2005 Mar 27; 37(2):1271-3. PubMed ID: 15848692
    [Abstract] [Full Text] [Related]

  • 8. The impact of delayed graft function of the kidney on the pancreas allograft in simultaneous kidney-pancreas transplantation.
    Reddy KS, Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May 27; 36(4):1078-9. PubMed ID: 15194374
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for delayed kidney function and impact of delayed function on patient and graft survival in adult graft recipients.
    Pieringer H, Biesenbach G.
    Clin Transplant; 2005 Jun 27; 19(3):391-8. PubMed ID: 15877804
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delayed graft function does not harm the future of donation-after-cardiac death in kidney transplantation.
    Le Dinh H, Weekers L, Bonvoisin C, Krzesinski JM, Monard J, de Roover A, Squifflet JP, Meurisse M, Detry O.
    Transplant Proc; 2012 Nov 27; 44(9):2795-802. PubMed ID: 23146527
    [Abstract] [Full Text] [Related]

  • 12. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
    Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R.
    Transplantation; 2010 Jan 15; 89(1):97-103. PubMed ID: 20061925
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recipient and donor body mass index as important risk factors for delayed kidney graft function.
    Weissenbacher A, Jara M, Ulmer H, Biebl M, Bösmüller C, Schneeberger S, Mayer G, Pratschke J, Öllinger R.
    Transplantation; 2012 Mar 15; 93(5):524-9. PubMed ID: 22362367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug 15; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE.
    Transplant Proc; 2005 Oct 15; 37(8):3527-30. PubMed ID: 16298650
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus antibody status and kidney transplantation.
    Terasaki PI, Yuge J, Cecka JM, Gjertson DW.
    Clin Transpl; 1994 Oct 15; ():509-18. PubMed ID: 7547579
    [Abstract] [Full Text] [Related]

  • 20. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C.
    Nephrol Dial Transplant; 2006 Jun 15; 21(6):1689-96. PubMed ID: 16490743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.